Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recurrence × Tranexamic Acid × Dermatologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Skin Neoplasms 1 Recurrence 1 Neoplasms 1 Melanoma 1

Interventions

Peripheral Blood Stem Cell Transplantation 18 fludarabine phosphate 16 Mycophenolic Acid 14 Cyclophosphamide 14 Cyclosporine 13 Whole-Body Irradiation 12 Tacrolimus 9 Radiotherapy 8 Methotrexate 8 Busulfan 8 Melphalan 7 Antilymphocyte Serum 7 pembrolizumab 6 Filgrastim 6 Nivolumab 5 Methylprednisolone 5 Etoposide 5 Sirolimus 4 Therapeutics 3 Polymerase Chain Reaction 3 Cord Blood Stem Cell Transplantation 3 Amplified Fragment Length Polymorphism Analysis 3 sargramostim 2 merphos 2 bempegaldesleukin 2 Vitamin B 12 2 Transplantation 2 Surgical Procedures, Operative 2 Prednisone 2 Oxaliplatin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05899465 2025-03-18

PRIME

University of Aarhus

Phase 3 Recruiting

Melanoma, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡